List of Tables
Table 1. Global Acute Myeloid Leukemia Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Targeted Therapy
Table 4. Global Acute Myeloid Leukemia Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Acute Myeloid Leukemia Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Acute Myeloid Leukemia Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Acute Myeloid Leukemia Market Share by Region (2019-2024)
Table 8. Global Acute Myeloid Leukemia Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Acute Myeloid Leukemia Market Share by Region (2025-2030)
Table 10. Acute Myeloid Leukemia Market Trends
Table 11. Acute Myeloid Leukemia Market Drivers
Table 12. Acute Myeloid Leukemia Market Challenges
Table 13. Acute Myeloid Leukemia Market Restraints
Table 14. Global Acute Myeloid Leukemia Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Acute Myeloid Leukemia Market Share by Players (2019-2024)
Table 16. Global Top Acute Myeloid Leukemia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Myeloid Leukemia as of 2023)
Table 17. Ranking of Global Top Acute Myeloid Leukemia Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Acute Myeloid Leukemia Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Acute Myeloid Leukemia Product Solution and Service
Table 21. Date of Enter into Acute Myeloid Leukemia Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Acute Myeloid Leukemia Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Acute Myeloid Leukemia Revenue Market Share by Type (2019-2024)
Table 25. Global Acute Myeloid Leukemia Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Acute Myeloid Leukemia Revenue Market Share by Type (2025-2030)
Table 27. Global Acute Myeloid Leukemia Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Acute Myeloid Leukemia Revenue Market Share by Application (2019-2024)
Table 29. Global Acute Myeloid Leukemia Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Acute Myeloid Leukemia Revenue Market Share by Application (2025-2030)
Table 31. North America Acute Myeloid Leukemia Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Acute Myeloid Leukemia Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Acute Myeloid Leukemia Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Acute Myeloid Leukemia Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Acute Myeloid Leukemia Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Acute Myeloid Leukemia Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Acute Myeloid Leukemia Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Acute Myeloid Leukemia Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Acute Myeloid Leukemia Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Acute Myeloid Leukemia Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Acute Myeloid Leukemia Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Acute Myeloid Leukemia Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Acute Myeloid Leukemia Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Acute Myeloid Leukemia Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Acute Myeloid Leukemia Market Size by Country (2025-2030) & (US$ Million)
Table 46. GSK Company Detail
Table 47. GSK Business Overview
Table 48. GSK Acute Myeloid Leukemia Product
Table 49. GSK Revenue in Acute Myeloid Leukemia Business (2019-2024) & (US$ Million)
Table 50. GSK Recent Development
Table 51. Novartis Company Detail
Table 52. Novartis Business Overview
Table 53. Novartis Acute Myeloid Leukemia Product
Table 54. Novartis Revenue in Acute Myeloid Leukemia Business (2019-2024) & (US$ Million)
Table 55. Novartis Recent Development
Table 56. Roche Company Detail
Table 57. Roche Business Overview
Table 58. Roche Acute Myeloid Leukemia Product
Table 59. Roche Revenue in Acute Myeloid Leukemia Business (2019-2024) & (US$ Million)
Table 60. Roche Recent Development
Table 61. Bristol-Myers Squibb Company Detail
Table 62. Bristol-Myers Squibb Business Overview
Table 63. Bristol-Myers Squibb Acute Myeloid Leukemia Product
Table 64. Bristol-Myers Squibb Revenue in Acute Myeloid Leukemia Business (2019-2024) & (US$ Million)
Table 65. Bristol-Myers Squibb Recent Development
Table 66. Celgene Company Detail
Table 67. Celgene Business Overview
Table 68. Celgene Acute Myeloid Leukemia Product
Table 69. Celgene Revenue in Acute Myeloid Leukemia Business (2019-2024) & (US$ Million)
Table 70. Celgene Recent Development
Table 71. Clavis Pharma ASA Company Detail
Table 72. Clavis Pharma ASA Business Overview
Table 73. Clavis Pharma ASA Acute Myeloid Leukemia Product
Table 74. Clavis Pharma ASA Revenue in Acute Myeloid Leukemia Business (2019-2024) & (US$ Million)
Table 75. Clavis Pharma ASA Recent Development
Table 76. Daiichi Sankyo Company Detail
Table 77. Daiichi Sankyo Business Overview
Table 78. Daiichi Sankyo Acute Myeloid Leukemia Product
Table 79. Daiichi Sankyo Revenue in Acute Myeloid Leukemia Business (2019-2024) & (US$ Million)
Table 80. Daiichi Sankyo Recent Development
Table 81. Eisai Company Detail
Table 82. Eisai Business Overview
Table 83. Eisai Acute Myeloid Leukemia Product
Table 84. Eisai Revenue in Acute Myeloid Leukemia Business (2019-2024) & (US$ Million)
Table 85. Eisai Recent Development
Table 86. Teva Company Detail
Table 87. Teva Business Overview
Table 88. Teva Acute Myeloid Leukemia Product
Table 89. Teva Revenue in Acute Myeloid Leukemia Business (2019-2024) & (US$ Million)
Table 90. Teva Recent Development
Table 91. Sunesis Pharmaceuticals Company Detail
Table 92. Sunesis Pharmaceuticals Business Overview
Table 93. Sunesis Pharmaceuticals Acute Myeloid Leukemia Product
Table 94. Sunesis Pharmaceuticals Revenue in Acute Myeloid Leukemia Business (2019-2024) & (US$ Million)
Table 95. Sunesis Pharmaceuticals Recent Development
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Myeloid Leukemia Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Acute Myeloid Leukemia Market Share by Type: 2023 VS 2030
Figure 3. Chemotherapy Features
Figure 4. Targeted Therapy Features
Figure 5. Global Acute Myeloid Leukemia Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Acute Myeloid Leukemia Market Share by Application: 2023 VS 2030
Figure 7. Adults Case Studies
Figure 8. Children Case Studies
Figure 9. Acute Myeloid Leukemia Report Years Considered
Figure 10. Global Acute Myeloid Leukemia Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global Acute Myeloid Leukemia Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Acute Myeloid Leukemia Market Share by Region: 2023 VS 2030
Figure 13. Global Acute Myeloid Leukemia Market Share by Players in 2023
Figure 14. Global Top Acute Myeloid Leukemia Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Acute Myeloid Leukemia as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by Acute Myeloid Leukemia Revenue in 2023
Figure 16. North America Acute Myeloid Leukemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America Acute Myeloid Leukemia Market Share by Country (2019-2030)
Figure 18. United States Acute Myeloid Leukemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada Acute Myeloid Leukemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe Acute Myeloid Leukemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Acute Myeloid Leukemia Market Share by Country (2019-2030)
Figure 22. Germany Acute Myeloid Leukemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France Acute Myeloid Leukemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. Acute Myeloid Leukemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy Acute Myeloid Leukemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia Acute Myeloid Leukemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries Acute Myeloid Leukemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific Acute Myeloid Leukemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Acute Myeloid Leukemia Market Share by Region (2019-2030)
Figure 30. China Acute Myeloid Leukemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan Acute Myeloid Leukemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea Acute Myeloid Leukemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia Acute Myeloid Leukemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India Acute Myeloid Leukemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia Acute Myeloid Leukemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America Acute Myeloid Leukemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Acute Myeloid Leukemia Market Share by Country (2019-2030)
Figure 38. Mexico Acute Myeloid Leukemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil Acute Myeloid Leukemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Acute Myeloid Leukemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Acute Myeloid Leukemia Market Share by Country (2019-2030)
Figure 42. Turkey Acute Myeloid Leukemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia Acute Myeloid Leukemia Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. GSK Revenue Growth Rate in Acute Myeloid Leukemia Business (2019-2024)
Figure 45. Novartis Revenue Growth Rate in Acute Myeloid Leukemia Business (2019-2024)
Figure 46. Roche Revenue Growth Rate in Acute Myeloid Leukemia Business (2019-2024)
Figure 47. Bristol-Myers Squibb Revenue Growth Rate in Acute Myeloid Leukemia Business (2019-2024)
Figure 48. Celgene Revenue Growth Rate in Acute Myeloid Leukemia Business (2019-2024)
Figure 49. Clavis Pharma ASA Revenue Growth Rate in Acute Myeloid Leukemia Business (2019-2024)
Figure 50. Daiichi Sankyo Revenue Growth Rate in Acute Myeloid Leukemia Business (2019-2024)
Figure 51. Eisai Revenue Growth Rate in Acute Myeloid Leukemia Business (2019-2024)
Figure 52. Teva Revenue Growth Rate in Acute Myeloid Leukemia Business (2019-2024)
Figure 53. Sunesis Pharmaceuticals Revenue Growth Rate in Acute Myeloid Leukemia Business (2019-2024)
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed